LLMs-Universal-Life-Science-and-Clinical-Skills- bioinformatics-singlecell
Single-cell and multi-omic analysis for hematology, oncology, and translational biology. Use when working with scRNA-seq, CITE-seq, scATAC-seq, multiome, trajectory analysis, batch correction, cell typing, differential expression, or publication-ready figures in Scanpy, scvi-tools, Seurat, or MuData workflows.
install
source · Clone the upstream repo
git clone https://github.com/mdbabumiamssm/LLMs-Universal-Life-Science-and-Clinical-Skills-
Claude Code · Install into ~/.claude/skills/
T=$(mktemp -d) && git clone --depth=1 https://github.com/mdbabumiamssm/LLMs-Universal-Life-Science-and-Clinical-Skills- "$T" && mkdir -p ~/.claude/skills && cp -r "$T/Skills/User_Collections/Babu/bioinformatics-singlecell" ~/.claude/skills/mdbabumiamssm-llms-universal-life-science-and-clinical-skills-bioinformatics-sin && rm -rf "$T"
manifest:
Skills/User_Collections/Babu/bioinformatics-singlecell/SKILL.mdsource content
Single-Cell Analysis
Run practical single-cell analysis workflows with emphasis on QC discipline, interpretable annotations, and reproducible outputs.
Workflow
- Confirm assay type, species, reference build, sample design, and expected outputs before touching code.
- Inspect raw inputs and metadata first; check barcode structure, feature naming, batch labels, and sample-level covariates.
- Apply assay-appropriate QC thresholds rather than hard-coding generic cutoffs across datasets.
- Normalize, integrate, cluster, and annotate with methods that match the study design; preserve raw counts when downstream models need them.
- Separate exploratory clustering from biologic claims; validate major labels with marker genes, orthogonal metadata, or reference mapping.
- Report thresholds, software versions, random seeds, and the exact objects written to disk.
Guardrails
- Flag doublets, ambient RNA, batch leakage, and low-complexity samples before interpreting clusters.
- Do not overstate automated annotation; list competing labels when marker support is mixed.
- For disease cohorts, distinguish malignant state, lineage identity, and treatment effect.
- Preserve donor and sample identity through every merge or integration step.
References
- Read
for lineage and megakaryocyte markers.references/cell_markers.md - Read
for a compact end-to-end checklist.references/workflow-checklist.md